Health
Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds – News-Medical.Net
A new study evaluates the safety, immunogenicity, and efficacy of the BNT162b2 in children who were 5 to 11 years of age.
Vaccination against coronavirus disease 2019 (COVID-19) has been considered to be the most effective way to reduce the mortality and morbidity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Several vaccine candidates have…
-
Noosa News22 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General20 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
General24 hours agoMan dies at shopping centre car park at Charlestown following reports of assault
-
Noosa News23 hours agoSchoolgirls hit by fishtailing car in terrifying crash in Bellbird Park, Ipswich